BBH

Fund Description
The VanEck Vectors Biotech ETF (BBH) seeks to replicate as closely as possible, before fees and expenses, the price and yield performance of the Market Vectors US Listed Biotech 25 Index (MVBBHTR). The Index is a rules-based index intended to track the overall performance of 25 of the largest U.S. listed, publicly traded biotech companies.
Fund Profile
Fund Name VanEck Vectors Biotech ETF
Fund Exchange Ticker BBH
Fund Sponsor Van Eck Associates Corporation
Fund ISIN US92189F7261
Net Expense Ratio 0.35 %
Fund Inception Date 20 December 2011
Fund Legal Structure ETF (Open end fund)
Exchange NASDAQ
Listing Country Code US
Fund Investment Objective
ETF Type Specific Global or ExUS Equities - Industry Sector
Asset Class Equities (Stocks)
Index Linked Passive
Index Name Market Vectors US Listed Biotech 25 Index
Index Provider Market Vectors
Currency Hedged No
Inverse / Leveraged Not Applicable
Developed / Emerging Developed Market Funds
Market Capitalization Range Broad Market / Multi-Cap
Growth Value Core / Blend
Continent Not Applicable
Key Statistics
Return As of Date 26 October 2020
Asset Under Management 471.11 Million (USD)
1 Month Total Return -1.35 %
Year To Date Return 12.32 %
1 Year Total Return 26.50 %
3 Year Annualized Total Return 6.84 %
NAV 157.22
Share Outstanding 2,996,500
Top 10 Holdings (23 October 2020)
Constituent Name Constituent Ticker Constituent Type Weighting
AMGEN INC AMGN EQUI 0.1436000000
GILEAD SCIENCES INC GILD EQUI 0.0727000000
REGENERON PHARMACEUTICALS REGN EQUI 0.0561000000
MODERNA INC MRNA EQUI 0.0551000000
IMMUNOMEDICS INC IMMU EQUI 0.0548000000
IQVIA HOLDINGS INC IQV EQUI 0.0514000000
ALEXION PHARMACEUTICALS INC ALXN EQUI 0.0499000000
ILLUMINA INC ILMN EQUI 0.0483000000
BIOGEN INC BIIB EQUI 0.0480000000
Seagen Inc SGEN EQUI 0.0474000000